These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7828413)

  • 1. Validation of a single point flow cytometric assay for determining P-glycoprotein activity in multidrug resistant cell lines.
    Chin-Yee I; Crowther MA; Keeney M; Wright L; Daly S
    Clin Lab Haematol; 1994 Sep; 16(3):261-72. PubMed ID: 7828413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia.
    Ross DD; Wooten PJ; Sridhara R; Ordóñez JV; Lee EJ; Schiffer CA
    Blood; 1993 Aug; 82(4):1288-99. PubMed ID: 8102561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel bioassay for P-glycoprotein functionality using cytochalasin D.
    Elbling L; Berger W; Weiss RM; Printz D; Fritsch G; Micksche M
    Cytometry; 1998 Mar; 31(3):187-98. PubMed ID: 9515718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproducible flow cytometric methodology for measuring multidrug resistance in leukaemic blasts.
    Pallis M; Turzanski J; Langabeer S; Russell NH
    Adv Exp Med Biol; 1999; 457():77-88. PubMed ID: 10500783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
    Van Acker KL; Van Hove LM; Boogaerts MA
    Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance.
    Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B
    Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The modulating effect of PSC 833, cyclosporin A, verapamil and genistein on in vitro cytotoxicity and intracellular content of daunorubicin in childhood acute lymphoblastic leukemia.
    den Boer ML; Pieters R; Kazemier KM; Janka-Schaub GE; Henze G; Veerman AJ
    Leukemia; 1998 Jun; 12(6):912-20. PubMed ID: 9639420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new method for a quantitative assessment of P-glycoprotein-related multidrug resistance in tumour cells.
    Homolya L; Holló M; Müller M; Mechetner EB; Sarkadi B
    Br J Cancer; 1996 Apr; 73(7):849-55. PubMed ID: 8611394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influx of daunorubicin in multidrug resistant Ehrlich ascites tumour cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil.
    Nielsen D; Maare C; Skovsgaard T
    Biochem Pharmacol; 1995 Aug; 50(4):443-50. PubMed ID: 7646548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of chemosensitizers on resistance mechanisms in daunorubicin-resistant Ehrlich ascites tumour cells.
    Nielsen D; Eriksen J; Maare C; Friche E; Skovsgaard T
    Cancer Chemother Pharmacol; 2002 Jun; 49(6):453-60. PubMed ID: 12107549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saturable P-glycoprotein kinetics assayed by fluorescence studies of drug efflux from suspended human KB8-5 cells.
    Ghauharali RI; Westerhoff HV; Dekker H; Lankelma J
    Biochim Biophys Acta; 1996 Jan; 1278(2):213-22. PubMed ID: 8593279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of P-glycoprotein expression and drug efflux in human soft tissue and bone sarcomas.
    Kunikane H; Zalupski MM; Ramachandran C; KuKuruga MA; Lucas D; Ryan JR; Krishan A
    Cytometry; 1997 Aug; 30(4):197-203. PubMed ID: 9298839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ability of verapamil to restore intracellular accumulation of anthracyclines in multidrug resistant cells depends on the kinetics of their uptake.
    Mankhetkorn S; Garnier-Suillerot A
    Eur J Pharmacol; 1998 Feb; 343(2-3):313-21. PubMed ID: 9570481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
    Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
    J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential gene expression of P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and lung resistance protein: functional activity of P-gp and MRP present in the doxorubicin-resistant human K562 cell lines.
    Grandjean F; Brémaud L; Verdier M; Robert J; Ratinaud MH
    Anticancer Drugs; 2001 Mar; 12(3):247-58. PubMed ID: 11290872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric functional analysis of multidrug resistance by Fluo-3: a comparison with rhodamine-123.
    Koizumi S; Konishi M; Ichihara T; Wada H; Matsukawa H; Goi K; Mizutani S
    Eur J Cancer; 1995 Sep; 31A(10):1682-8. PubMed ID: 7488425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two methods to detect P-glycoprotein in patients with chronic lymphocytic leukaemia.
    Chin-Yee I; Alshammari S; Anderson L; Kadri M; Keeney M
    Clin Lab Haematol; 1996 Jun; 18(2):99-104. PubMed ID: 8866142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of low-level expression of P-glycoprotein in ACHN renal adenocarcinoma cells.
    Kawamoto S; Deguchi T; Nezasa S; Yamada S; Okano M; Kawada Y
    Jpn J Cancer Res; 1996 May; 87(5):475-9. PubMed ID: 8641984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells.
    Hegewisch-Becker S; Faltz C; Hossfeld DK
    Eur J Haematol; 1996; 56(1-2):12-22. PubMed ID: 8599988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular pharmacology of mitoxantrone in p-glycoprotein-positive and -negative human myeloid leukemic cell lines.
    Consoli U; Van NT; Neamati N; Mahadevia R; Beran M; Zhao S; Andreeff M
    Leukemia; 1997 Dec; 11(12):2066-74. PubMed ID: 9447822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.